; table of contents. Sec. 2. Definitions. Title I—Improving Fentanyl Surveillance Sec. 101. Enhanced drug surveillance. Sec. 102. Collection of overdose data. Sec. 103. Public health support for law enforcement. Sec. 104. Fentanyl detection. Sec. 105. Grants to improve public health surveillance in forensic laboratories. Title II—Stemming the Supply of Fentanyl Sec. 201. Report on countries that produce synthetic drugs. Sec. 202. GAO report on international mail and cargo screening. Title III—Overdose Prevention and Substance Use Disorder Treatment Programs Sec. 301. Opioid treatment education. Sec. 302. Study on naloxone access. Sec. 303. Increasing access to medication for opioid overdose reversal. Sec. 304. Grant program on harms of drug misuse. Sec. 305. Good Samaritan immunity. Sec. 306. Report on overdose prevention centers. Sec. 307. Prisons and substance use disorder treatment. 2. Definitions In this Act, except as otherwise provided: (1) The term Assistant Secretary means the Assistant Secretary for Mental Health and Substance Use. (2) The term Secretary means the Secretary of Health and Human Services. (3) The term fentanyl-related substance has the meaning given the term in section 1308.11(h)(30)(i) of title 21, Code of Federal Regulations (or successor regulations). I Improving Fentanyl Surveillance 101. Enhanced drug surveillance (a) CDC surveillance program Title III of the Public Health Service Act ( 42 U.S.C. 241 et seq. ) is amended by inserting after section 317V of such Act ( 42 U.S.C. 247b–24 ) the following: 317W. Enhanced drug surveillance (a) In general The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall enhance the Overdose Data to Action drug surveillance program of the Centers and other drug surveillance programs by— (1) encouraging States, political subdivisions of States, and territories to participate